Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy.
about
Oxidative stress associated with neuronal apoptosis in experimental models of epilepsyAdvantages of repeated low dose against single high dose of kainate in C57BL/6J mouse model of status epilepticus: behavioral and electroencephalographic studiesTonic facilitation of glutamate release by presynaptic NR2B-containing NMDA receptors is increased in the entorhinal cortex of chronically epileptic ratsDV21 decreases excitability of cortical pyramidal neurons and acts in epilepsy.A role for leukocyte-endothelial adhesion mechanisms in epilepsyDoes pilocarpine-induced epilepsy in adult rats require status epilepticus?Global expression profiling in epileptogenesis: does it add to the confusion?P-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human EpilepsyPrevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.Increased stathmin expression strengthens fear conditioning in epileptic rats.A Low Mortality, High Morbidity Reduced Intensity Status Epilepticus (RISE) Model of Epilepsy and Epileptogenesis in the Rat.Factors affecting outcomes of pilocarpine treatment in a mouse model of temporal lobe epilepsy.Contribution of protease-activated receptor 1 in status epilepticus-induced epileptogenesis.The pilocarpine model of temporal lobe epilepsyMinimal latency to hippocampal epileptogenesis and clinical epilepsy after perforant pathway stimulation-induced status epilepticus in awake ratsA novel positron emission tomography imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood-brain barrierRole of hormones and neurosteroids in epileptogenesis.Animal models for the development of new neuropharmacological therapeutics in the status epilepticus.Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventionsAnimal models of temporal lobe epilepsy following systemic chemoconvulsant administrationAutonomic and cellular mechanisms mediating detrimental cardiac effects of status epilepticus.Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.Depression of glutamate and GABA release by presynaptic GABAB receptors in the entorhinal cortex in normal and chronically epileptic rats.Low-frequency repetitive transcranial magnetic simulation prevents chronic epileptic seizure.Proepileptic influence of a focal vascular lesion affecting entorhinal cortex-CA3 connections after status epilepticusStatus epilepticus induces cardiac myofilament damage and increased susceptibility to arrhythmias in rats.Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.Strain differences affect the induction of status epilepticus and seizure-induced morphological changes.Do proconvulsants modify or halt epileptogenesis? Pentylenetetrazole is ineffective in two rat models of temporal lobe epilepsy.Enriched environment attenuates behavioral seizures and depression in chronic temporal lobe epilepsy.Neuroprotective effects of vitamin D alone or in combination with lamotrigine against lithium-pilocarpine model of status epilepticus in rats.Smad anchor for receptor activation contributes to seizures in temporal lobe epilepsy.Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats.Epileptic pilocarpine-treated rats exhibit aberrant hippocampal EPSP-spike potentiation but retain long-term potentiation.Increased expression of receptor for activated C kinase 1 in temporal lobe epilepsy.MK-801 prevents overexpression of multidrug resistance protein 2 after status epilepticus.Status Epilepticus: Behavioral and Electroencephalography Seizure Correlates in Kainate Experimental Models.Gastrodin Reduces the Severity of Status Epilepticus in the Rat Pilocarpine Model of Temporal Lobe Epilepsy by Inhibiting Nav1.6 Sodium Currents.Long non-coding RNA H19 contributes to apoptosis of hippocampal neurons by inhibiting let-7b in a rat model of temporal lobe epilepsy.
P2860
Q26823122-02A987B4-9552-4D78-A9FB-ACF37DB4124FQ27334351-71F6443C-8157-44F5-BF3C-3B739FC913AAQ28573102-38952226-EF1D-41B3-888B-5F8B455ECCE0Q29994691-4245247F-2CA2-4FF8-BEFA-798CFF047353Q30488791-BE4BA402-51C7-44DB-BCE8-B8E4402205EFQ33463300-FA8A1A1B-822D-4A38-BC9E-7347F2E8F951Q33588199-9DC3FBBC-52D4-4FFE-A25F-86C201E101B0Q33875127-A5D5202B-B190-4139-A0C0-AADC70CBBEB2Q34458158-078A5250-85F6-4633-A36B-205196088C24Q34607365-1481B7D0-8715-4511-BF9E-111654AB2421Q35933791-6D2F897C-EF41-4466-8F47-6D274B027FE0Q36279135-FC0548BD-7FA1-4FA4-A2BF-77DF92E24148Q36380440-4612E353-FC38-4845-91A7-F4076CB2441FQ36841686-58338C48-9501-4B4A-9F5F-AD6E148518F8Q36924720-84BF5B4B-1339-45CB-A20B-C17F95D39F03Q36955931-6235A207-AA66-4B36-90D0-1E698D2CAAB1Q37057683-E584B2C1-203E-4A4A-9754-1FDEA3650193Q37211763-D2D4523E-0DCB-476E-8181-BC2070230404Q37225136-2D5A7373-2264-4A15-BCC6-AAF95598DE6EQ38376884-2B272EF9-D8D5-49B6-B2A4-15B8AC318D50Q39012866-87FF3338-0A04-4599-973F-5567F303C818Q39126886-54853C74-1A43-4730-B482-55E7F4909685Q41754933-EEE988F9-9DF3-49B8-B604-00CFCF055B92Q41845963-2CEAFDB6-A3E6-4391-B40F-BB9651064DC1Q42144414-CC894713-9542-487B-849F-D096F58A7385Q43263731-A18A5633-1BB9-49D6-BC9D-C5CD63A41638Q43959049-8729CBEF-6E2D-4F09-B99F-F7A85B99973FQ44963292-B8CA055B-79F4-4FA3-9C9D-7E7F22F9BEE5Q45786063-E7A74579-49A5-4A6C-A147-C200FF536553Q47322718-74128BEF-E7B9-4716-9F96-0921ACC1A1B6Q47979564-39484E8B-E38C-46B1-9A14-3A0ABD3D42DCQ48107016-ADC25347-48C9-4B8E-91DF-2FAB425AF527Q48201303-BA23E9AF-A6B8-444B-85DA-13928566086EQ48304353-85FFE885-A875-4A5B-AB81-83B5E9B313DAQ48344805-9B177B1F-6F9E-4AD4-BA20-E63BA8853AA7Q48490505-8433598D-3B26-4FF5-9A03-3485E59421DEQ49310896-E0C881F8-294B-4B8F-9D87-642AFB713EA3Q50483987-DFA163B1-8434-44A4-93BB-62C4D09567B0Q55539165-127053BC-0163-4B84-AC08-419208DA6908
P2860
Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Repeated low-dose treatment of ...... n of rats developing epilepsy.
@en
Repeated low-dose treatment of ...... n of rats developing epilepsy.
@nl
type
label
Repeated low-dose treatment of ...... n of rats developing epilepsy.
@en
Repeated low-dose treatment of ...... n of rats developing epilepsy.
@nl
prefLabel
Repeated low-dose treatment of ...... n of rats developing epilepsy.
@en
Repeated low-dose treatment of ...... n of rats developing epilepsy.
@nl
P2093
P1433
P1476
Repeated low-dose treatment of ...... n of rats developing epilepsy.
@en
P2093
P304
P356
10.1016/S0920-1211(01)00272-8
P577
2001-08-01T00:00:00Z